YuChen Zhang, Man Nie, Yi Cao, Zhiming Li, He Huang, Guowei Li, Xiuhua Sun, Panpan Liu, Yan Gao, Xiaojie Fang, Bing Bai, Jun Cai, Lirong Li, Yingxian Liu, Sihua Peng, Huiqiang Huang, Yi Xia, Qingqing Cai. "Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial." Nature Communications, 2026. doi:10.1038/s41467-026-71241-1